pros and cons of microdosing tirzepatide GLP-1s: Does It Work? Risks Benefits Thinking About Microdosing GLP-1? 5

Shared decision-making between the patient and their care team is indicated to decide whether to start, continue or discontinue GLP-1 therapy in the setting of a new diagnosis of NAION or in certain risk contexts, considering the individual patient characteristics and clinical scenario, the guidance article authors wrote

Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells

Follow-up visits should track weight loss progress, assess for adverse effects (including mood changes), evaluate adherence to lifestyle modifications, and adjust treatment as needed

10 M final) were added continuously to the culture media and replaced every 4872 h